Cover Image

Study design considerations to assess the impact of potential drug-drug interactions in first‐in‐human studies in oncology drug development

Saved in:

Bibliographic Details
Main Authors:	Sriram Subramaniam (Author), Stacy S. Shord (Author), Ruby Leong (Author), Kelly Norsworthy (Author), Atiqur Rahman (Author), Brian Booth (Author), Olanrewaju Okusanya (Author)
Format:	Book
Published:	Wiley, 2023-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
by: Stacy S. Shord, et al.
Published: (2023)

Utility of Physiologically Based Pharmacokinetic Modeling to Investigate the Impact of Physiological Changes of Pregnancy and Cancer on Oncology Drug Pharmacokinetics
by: Xinxin Yang, et al.
Published: (2023)

FDA regulatory considerations for oncology drug development
by: Hanlim Moon, et al.
Published: (2024)

Oncology nurses awareness of drug interactions
by: Azize Karahan, et al.
Published: (2015)

Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
by: Mariam A. Ahmed, et al.
Published: (2020)

Drug binding and drug-drug interaction considerations in individuals with obesity before and after bariatric surgery: A retrospective cross-sectional study
by: Emerita Quintina de Andrade Moura, et al.
Published: (2023)

Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight
by: Giang H. Ta, et al.
Published: (2024)

Drug interactions in female oncologic inpatients: differences among databases
by: Patricia Moriel, et al.
Published: (2013)

Drug interactions in female oncologic inpatients: differences among databases
by: Patricia Moriel, et al.
Published: (2013)

Evaluation of potential drug-drug interactions with medical cannabis
by: Jessie Jia Yi Ho, et al.
Published: (2024)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
by: Louis Létinier, et al.
Published: (2019)

Pharmacokinetic Drug-Drug Interactions and Herb-Drug Interactions
by: Min-Koo Choi, et al.
Published: (2021)

Drug-Drug Interactions
Published: (2021)

Prevalence, predictors and outcomes of potential drug-drug interactions in left ventricular failure: considerable factors for quality use of medicines
by: Inamul Haq, et al.
Published: (2020)

Drug-drug interactions of tacrolimus
by: Rančić Nemanja K., et al.
Published: (2015)

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions
by: Martina Hahn, et al.
Published: (2021)

Renal drug transporters and their significance in drug-drug interactions
by: Jia Yin, et al.
Published: (2016)

Optimizing the Therapeutic Window of Targeted Drugs in Oncology: Potency‐Guided First‐in‐Human Studies
by: Matthew J. Goldstein, et al.
Published: (2021)

The Prevalence of the Potential Drug-Drug Interactions Involving Anticancer Drugs in China: A Retrospective Study
by: Weilan WANG, et al.
Published: (2019)

Editorial: Drug-drug interactions in pharmacology
by: Simona Pichini, et al.
Published: (2023)

Study of Potential Drug-Drug Interactions in Prescriptions of University- Based Pharmacies
by: Sarah Mousavi, et al.
Published: (2015)

Innovative Approaches to Optimize Clinical Transporter Drug-Drug Interaction Studies
by: Sabina Paglialunga, et al.
Published: (2024)

Drug-Diagnostics Co-Development in Oncology
by: Jan Trost Jorgensen
Published: (2014)

Nanotechnology and Drug Delivery: An Update in Oncology
by: Tait Jones, et al.
Published: (2011)

Direct Acting Antiviral Drugs: Pharmacokinetics and Drug-Drug Interactions
by: Marina Barakat, et al.
Published: (2022)

Transporter-Mediated Drug-Drug Interactions with Oral Antidiabetic Drugs
by: Jörg König, et al.
Published: (2011)

Opioid Drug-Drug-Drug Interactions and Unintentional Traumatic Injury: Screening to Detect Three-Way Drug Interaction Signals
by: Emily K. Acton, et al.
Published: (2022)

Prediction of the drug-drug interaction potential of the α1‐acid glycoprotein bound, CYP3A4/CYP2C9 metabolized oncology drug, erdafitinib
by: Loeckie De Zwart, et al.
Published: (2021)

Associated factors of potential drug-drug interactions and drug-food interactions in patients with multiple sclerosis
by: Jane Louisa Debus, et al.
Published: (2022)

A Minimal Information Model for Potential Drug-Drug Interactions
by: Harry Hochheiser, et al.
Published: (2021)

Drug-drug interactions in neonatal intensive care: A prospective cohort study
by: Haline Tereza Costa, et al.
Published: (2021)

Pilot study: Evaluation of potential drug-drug interactions in hospitalized pediatric patients
by: Fabiola Medina-Barajas, et al.
Published: (2020)

Biomembrane models and drug-biomembrane interaction studies: Involvement in drug design and development
by: R Pignatello, et al.
Published: (2011)

Potential Drug-Drug Interactions in Ambulatory Patients with Hypertension: a Retrospective Study
by: Marcha Debby Saraswati, et al.
Published: (2022)

Drug-drug interaction-related uncontrolled glycemia
by: Mohamed Anwar Hammad, et al.
Published: (2017)

Drug-drug interactions: The importance of medication reconciliation
by: Mahin Jamshidi Makiani, et al.
Published: (2017)

Magnitude of Drug-Drug Interactions in Special Populations
by: Sara Bettonte, et al.
Published: (2022)

Drug-drug interactions in the new antiepileptic drugs: focus to perampanel and zonisamide
by: Y. B. Belousov
Published: (2014)

Adverse drug reactions and correlations with drug-drug interactions: A retrospective study of reports from 2011 to 2020
by: Huaqiao Jiang, et al.
Published: (2022)

Artificial Intelligence in Oncology Drug Discovery and Development
Published: (2020)